Verismo Therapeutics Achieves FDA Clearance for Phase I Trial of its CAR T Therapy
Penn spinout Verismo Therapeutics has received FDA clearance for a Phase I trial of its CAR-T therapy, SynKIR-310.
iECURE Receives Three FDA Designations for its In Vivo Gene Insertion Program
iEcure, a gene-editing company spun out of Penn and co-founded by Dr. Wilson, has received three special designations from the FDA for its new treatment, ECUR-506.
Penn Startups Recognized in Labiotech’s List of “Eight companies spearheading Philadelphia’s biotech industry”
After emerging from stealth mode in 2023, BlueWhale aims to develop a technology platform and product portfolio that will provide the benefits of cell therapy to patients more quickly.
The Chamber of Commerce for Greater Philadelphia Recognizes the Philadelphia Region as Leader in Cell and Gene Therapy
The report highlights Penn’s significant contributions to the growth of the CGT sector in Greater Philadelphia, including spinning out over 40 CGT companies since 2018.
Philadelphia Ranks 4th Among National Life Sciences Markets in New Colliers Report
In the recently released Colliers 2024 Life Sciences Report, Philadelphia ranked #4 nationwide, with Boston, the San Francisco Bay Area and San Diego ranking first, second and third, respectively.
Moderna Receives FDA Approval for RSV Vaccine Based on Penn Technology
RSV is a highly contagious seasonal respiratory virus and a leading cause of lower respiratory tract infections and pneumonia.
Penn Arts and Sciences’ MindCORE Neuroimaging Facility at Pennovation Works
The machine is the centerpiece of the new Neuroimaging Facility where scientists will study the mind-brain connection in-depth.
Tech Talks: Bridging Academia and Innovation in Philadelphia’s Tech Hub
On April 24th, 2024, Penn hosted an event co-organized by the Mack Institute for Innovation Management and the City of Philadelphia Department of Commerce.
2023 President’s Prize Winners: Where They Are Now?
The 2023 President’s Innovation Prize (PIP) and President’s Engagement Prize (PEP) winners have each made significant strides over the course of the past year.
LNP Research from the Mitchell Lab is Highlighted in the Philadelphia Inquirer
Mike Mitchell, PhD, was interviewed recently by the Philadelphia Inquirer about his cutting-edge research in lipid nanoparticles (LNPs), which are crucial for delivering mRNA into the body's cells.